282 related articles for article (PubMed ID: 18945306)
21. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
[TBL] [Abstract][Full Text] [Related]
22. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
El-Mofty M; El-Darouty M; Salonas M; Bosseila M; Sobeih S; Leheta T; Nada H; Tawdy A; Amin I; El-Enany G
Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):281-6. PubMed ID: 16313238
[TBL] [Abstract][Full Text] [Related]
23. [Mycosis fungoides in childhood and adolescence with clonal T-cell receptor gamma gene rearrangement. Two cases].
Krokowski M; Winzer M; Lange K; Thorns C; Gafumbegete E; Feller AC; Merz H
Hautarzt; 2003 Jun; 54(6):536-40. PubMed ID: 12759739
[TBL] [Abstract][Full Text] [Related]
24. Ichthyosiform mycosis fungoides.
Badawy E; D'Incan M; El Majjaoui S; Franck F; Fabricio L; Dereure O; Souteyrand P; Guillot B
Eur J Dermatol; 2002; 12(6):594-6. PubMed ID: 12459538
[TBL] [Abstract][Full Text] [Related]
25. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
Stern DK; Lebwohl M
J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
[TBL] [Abstract][Full Text] [Related]
26. Cytokine gene polymorphisms in patch-stage mycosis fungoides.
Hodak E; Akerman L; David M; Tambur AR; Kfir B; Maron L; Sulkes J; Klein T
Acta Derm Venereol; 2005; 85(2):109-12. PubMed ID: 15823901
[TBL] [Abstract][Full Text] [Related]
27. Treatment of mycosis fungoides with psoralen and long-wave ultraviolet light-A (PUVA).
Nozicková M; Simková M; Nozicka Z
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1987; 30(1):179-94. PubMed ID: 3481871
[No Abstract] [Full Text] [Related]
28. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
Coors EA; Von den Driesch P
Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024
[No Abstract] [Full Text] [Related]
29. Mycosis fungoides and Sezary syndrome: therapeutic approach and outcome in 113 patients.
Anadolu RY; Birol A; Sanli H; Erdem C; Türsen U
Int J Dermatol; 2005 Jul; 44(7):559-65. PubMed ID: 15985024
[TBL] [Abstract][Full Text] [Related]
30. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
[TBL] [Abstract][Full Text] [Related]
31. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.
Roenigk HH; Kuzel TM; Skoutelis AP; Springer E; Yu G; Caro W; Gilyon K; Variakojis D; Kaul K; Bunn PA
J Invest Dermatol; 1990 Dec; 95(6 Suppl):198S-205S. PubMed ID: 2258636
[TBL] [Abstract][Full Text] [Related]
32. Transfer factor therapy in mycosis fungoides: a double-blind study.
Thestrup-Pedersen K; Grunnet E; Zachariae H
Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma.
Chiarion-Sileni V; Bononi A; Fornasa CV; Soraru M; Alaibac M; Ferrazzi E; Redelotti R; Peserico A; Monfardini S; Salvagno L
Cancer; 2002 Aug; 95(3):569-75. PubMed ID: 12209749
[TBL] [Abstract][Full Text] [Related]
34. Ichthyosiform mycosis fungoides: an atypical variant of cutaneous T-cell lymphoma.
Hodak E; Amitay I; Feinmesser M; Aviram A; David M
J Am Acad Dermatol; 2004 Mar; 50(3):368-74. PubMed ID: 14988677
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of psoralens in mycosis fungoides.
Roenigk HH
Natl Cancer Inst Monogr; 1984 Dec; 66():179-83. PubMed ID: 6531026
[TBL] [Abstract][Full Text] [Related]
36. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
37. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides.
Bakels V; Van Oostveen JW; Geerts ML; Gordijn RL; Walboomers JM; Scheffer E; Meijer CJ; Willemze R
J Pathol; 1993 Jul; 170(3):249-55. PubMed ID: 8133398
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series.
Singh F; Lebwohl MG
J Am Acad Dermatol; 2004 Oct; 51(4):570-3. PubMed ID: 15389192
[TBL] [Abstract][Full Text] [Related]
40. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
Hagedorn M; Hasche E; Kober B; Sander CA
Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]